Epidemiologist Rimoin has spent two decades studying emerging infections in Central Africa, and has long advocated for surveillance systems that allow for their rapid identification and control. Last year, when mpox began to sweep the globe, Rimoin was an early, authoritative voice calling on public health officials to take the threat seriously. Although the threat of mpox has since waned, she urges continued vigilance against infections with the potential for global spread, including mpox. “Just because we are not seeing cases doesn’t mean we can certainly declare victory,” she told the Washington Post.
Anne Rimoin
Professor of Epidemiology and Gordon-Levin Endowed Chair in Infectious Diseases and Public Health, UCLA Fielding School of Public Health
More in Academia
Academia
Alberto Ascherio
Professor of epidemiology and nutrition, Harvard T.H. Chan School of Public Health
Academia
Euan Ashley
Professor of medicine and genomics, Stanford School of Medicine
Academia
Carolyn Bertozzi
Professor of chemistry, Stanford University
Academia
Kirsten Bibbins-Domingo
Editor-in-chief, JAMA
Academia
Maria Elena Bottazzi
Co-director, Texas Children’s Hospital Center for Vaccine Development
Academia
Daniel Dawes
Executive director, Global Health Equity Institute, Meharry Medical College
Academia
Amy Finkelstein
Professor of economics, MIT
Academia
Rachel Hardeman
Director, Center for Antiracism Research for Health Equity, UMN
Academia
Akiko Iwasaki
Professor of immunobiology, Yale School of Medicine
Academia
Jonathan Jackson
Executive director, CARE Research Center at Mass. General
Academia
Keaweʻaimoku Kaholokula
Chair, Native Hawaiian Health, University of Hawai‘i at Mānoa
Academia
Marc Lipsitch
Director of science, CDC Center for Forecasting and Outbreak Analytics
Academia
Valerie Montgomery Rice
President & CEO, Morehouse School of Medicine
Academia
Roderic Pettigrew
Dean, Intercollegiate School of Engineering Medicine, Texas A&M
Academia
Emily Wang
Professor, Yale School of Medicine